This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Artificial intelligence (AI) is rapidly transforming the healthcare industry, with its ability to process and analyze vast amounts of data. One example of how AI is already being used to personalize cancer treatment is in the field of precision medicine. Even just a year ago, we couldn’t fathom a cure for cancer. Now, we can.
From AI-powered insights to the rise of precision medicine, new trends are reshaping the way we connect with patients and healthcare providers. Precision Medicine: Targeting the Right Audience Precision medicine, with its focus on individualized treatment, offers a goldmine of opportunities for marketers.
The UK’s regulatory pathway and fast-track drug approval process enables companies to fast-track their ethics applications and combine their reviews. The regulators are the Medicines and Healthcare products Regulatory Agency (MHRA) and US Food and Drug Administration (FDA) respectively.
The demand for highly qualified individuals is never stronger in the fast-paced and always changing environment of healthcare. Competency-based training healthcare is a novel method emphasizing on the acquisition of the exact skills and information required for healthcare professionals to perform in their positions.
Access to medicines have persisting and systemic differences across the globe and within countries. It is estimated that nearly two billion people globally do not have access to essential medicines. Traditionally, pharmaceutical companies have not prioritized emerging markets as part of their access strategy.
As the healthcare sector grows, there is a clear trend towards the expansion of biologic therapeutic drugs and vaccines like the one developed by Novavax. Novavax is particularly sensitive to this matter and is looking for alternatives that will not only benefit the patients but align with a more ethical solution.
Applied AI Although AI promises a great return on investment, the pharma industry has been slow to adopt it due to ethical, regulatory, and compliance hurdles. Angela Tenuta Globalization and Health Equity Healthcare systems face challenges, including rising chronic diseases, aging populations, workforce shortages and sustainability concerns.
Healthcare consumerism has drastically changed the way healthcare professionals need to market and deliver their services. Today’s consumers expect a healthcare experience as innovative and digitally advanced as any other industry. Think of all the reasons someone might decide to switch healthcare providers: . Relocation.
When it comes to medical sales, compliance and ethical practices have taken center stage. Ethical medical sales practices encompass a range of principles and guidelines aimed at ensuring patient safety, regulatory adherence, fair competition, and ethical conduct in sales interactions.
With uses going beyond entertainment and into vital sectors like surgery, augmented reality (AR) is transforming the healthcare sector. Integration of AR in medicine marks a basic change in how operations are carried out, therefore improving patient outcomes and lowering surgical risks; it is not only a technological development.
Globalization and health equity: Healthcare is global, and patients are diverse. Integrating AI into marketing processes means considering ethical, regulatory, and compliance issues such as access, inherent bias, privacy, and transparency. More patients are being treated with better medicines as healthcare infrastructures improve.
Websites, mobile apps, and digital ads are more than just tools—they are lifelines connecting pharma companies to healthcare professionals and patients. Websites, mobile apps, and digital ads are more than just tools—they are lifelines connecting pharma companies to healthcare professionals and patients.
FACILITATE , (FrAmework for ClInicaL trIal participants’ daTA reutilisation for a fully Transparent and Ethical ecosystem) is a patient-driven legal framework that intends to help return clinical trial data to study participants, ready for re-use in further research or healthcare practice.
According to the European Medicines Agency (EMA), CTIS is now the single-entry point for sponsors and regulators of clinical trials for the submission and assessment of clinical trial data. The system includes a public, searchable database for healthcare professionals, patients, and other interested parties.
The healthcare industry today stands as the first and the most crucial one among other sectors. The development and innovations for healthcare services are unlimited. It helps doctors, medical students and patients to experience a new trendy setting in healthcare apps. Do you imagine how it would be in the future?
A new scheme from the Medicines and Healthcare products Regulatory Agency (MHRA) is set to cut the approval time for the lowest-risk clinical trials in the UK by over half. This will be the case if the trial sponsor can demonstrate the trial meets the MHRA’s criteria, such as safety issues of the investigational medicine.
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a first-of-its-kind trial to run this year to test psychedelic drugs as a treatment for major depressive disorder (MDD). For example, ethics applications can be fast-tracked and reviews can be combined.
Companies are invited to reapply each year to be evaluated based on how their policies, actions, and results are impacting the environment, ethics, labor and human rights, and sustainable procurement. Company policies, like the code of ethical conduct, are examples of governance that typically stem from the corporate level.
This activity should bring together relevant data sets which are collected by both the Medicines and Healthcare products Regulatory Agency (MHRA) and HRA. A new sixty-day limit would be implemented for those conducting a trial to respond to Requests for Further Information (RFI) from the MHRA or Research Ethics Committees (RECs).
Healthcare professionals are also catching up to the patient group, which has long been engaged on social media. Patient and healthcare professionals anticipate personalized, communication based on value. Content must follow legal and ethical requirements and be truthful, fair, and non-misleading.
Are you targeting healthcare providers (HCPs), patients, or payers? Follow FDA guidelines on advertising to ensure your messaging is accurate and ethical. Monitor Industry Trends Stay informed about market trends like the rise of telehealth, personalized medicine, and value-based care.
How hot is generative AI in healthcare innovation right now? While that might be a slight exaggeration, you can confidently bet that generative AI will revolutionize healthcare—and it won’t take long. Some say you could add “AI'' to your digital health startup’s name and double your funding goal before the week is out.
Sharing data across borders ensures access to safe tissues and cells for human application is ethical and supply quality is adequate, said the Council in a statement.
This summer, we started a research series on Current and Future AI Trends in Healthcare, where we surveyed over 150 physicians, and conducted both qualitative and quantitative research with pharma industry members from 20 different companies. 65% agreed that AI has had a net positive impact on the practice of medicine to date.
These trends are not only transforming how pharmaceutical companies engage with healthcare professionals and patients but also shaping the future of healthcare delivery. With the increasing digitization of healthcare, pharmaceutical companies are leveraging digital platforms to reach broader audiences more effectively.
Historically, the healthcare field hasn’t exactly been at the forefront of adopting the latest technology — but things have gotten a lot better over the past decade. For example, healthcare stakeholders now widely acknowledge AI’s pivotal role in the industry.
The National Institutes of Health (NIH)-funded project is being run by researchers at the University of South Florida in collaboration with Weill Cornell Medicine in New York City, 10 other institutions in the US and Canada, and with the help of French/US artificial intelligence specialist Owkin. ” It will be backed by $3.8
The Clarify Health Institute will be a trusted source of knowledge on the quality and efficiency of US healthcare and a driver of transparency across the industry. Our resolve to become the go-to resource for healthcare research and insights further solidifies Clarify’s rising authority within the market.”.
And this is where modern technologies and data-driven medical informatics can really bridge the gaps in rare disease research,” said Dr Joanne Hackett, head of Genomic and Precision Medicine at IQVIA, during a recent pharmaphorum webinar. Sharing data to find the right diagnosis.
But the role of AI in healthcare will go beyond this. healthcare, with its 17% share of GDP, is “the most disruptable industry in the world,” and “the first big carcass that AI is going to start to feed on.” Enabling Precision Medicine Every stakeholder is going to be impacted. And there’s more to come.
They seem to have an air of confidence, backed by the promise of modern medicine. At its core, a medical representative's job is to increase the awareness and use of their company's medical products, typically pharmaceuticals or medical equipment, by connecting with healthcare professionals. The Basics: What Does a Medical Rep Do?
This summer, we started a research series on Current and Future AI Trends in Healthcare, where we surveyed over 150 physicians, and conducted both qualitative and quantitative research with pharma industry members from 20 different companies. 65% agreed that AI has had a net positive impact on the practice of medicine to date.
Talking through their generic medicines, of which the company has more than 1,000 projects ongoing, Schultz noted that more than half of the leading medicines on the WHO’s list of medicines are Teva’s. Indeed, of the 281 WHO-listed essential medicines, 100% of respiratory treatments are Teva’s. The purpose of these?
In the pharmaceutical industry, CLM enables brands to: Understand Healthcare Professionals (HCPs) and Patients Better : Gain insights into the preferences and needs of HCPs and patients, enabling more relevant messaging. This reduces the risk of misinformation and ensures ethical marketing practices.
The Digital Medicine Society’s Library of Digital Endpoints surpassed 350 unique digital endpoints used for evaluating new medical products. Knowledge of the fundamentals of digital medicine – and how digital innovation can be deployed to support the needs of teams across the clinical trials enterprise – is critical.
By leveraging the most powerful patient-level data set in healthcare, Clarify will build greater transparency among stakeholders in the US healthcare system, as well as shine a light on how healthcare is functioning and how it can improve. Ezekiel Emanuel and Amol Navathe.
Here are some key takeaways: AI and machine learning will have applications throughout every phase and aspect of drug development and will open up previously unreachable frontiers of medicine. “AI Payers, too, will be challenged by AI- and machine learning-enabled advances in medicine. They have no ethics.
In 2025, pharmaceutical trends are redefining how brands connect with healthcare professionals (HCPs), patients, and stakeholders. Personalized Medicine and Precision Targeting Gone are the days of one-size-fits-all treatments. Introduction The pharmaceutical industry is transforming at lightning speed.
The healthcare industry is embracing digital health technologies to improve patient care and outcomes. A recent study found that nearly 65% of healthcare organizations have experienced a data breach in the past year, with the average cost of a data breach for a healthcare organization being $6.5
Physician groups are usually smaller than healthcare organizations and prefer to focus on a single specialty. They provide personalized care and are integral to the healthcare team. The company offers transplantation, neurosurgery, psychiatry, orthopedics, sports medicine and insurance services.
Regulatory Compliance and Ethical Considerations It may sound like an obvious statement, but to engage patient audiences as a commercial entity, someone needs to keep a regulatory eye on the program. Humanity, compassion, and empathy should form our constellation of north stars.
Nothing good is driving biohacking The reasons for getting into biohacking are varied, from challenging traditional scientific research to exploring alternative medicine, and often to stopping the natural aging process. Some biohackers, known as ‘grinders’, even seek to become superhuman cyborgs with the sole aim of optimizing their bodies.
Regulatory bodies such as the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) place great importance on data integrity in the pharmaceutical/life science industry. Ethical leadership is essential in promoting a culture of integrity within an organisation.
Companies working to integrate AI into their diagnostics products include GE Healthcare, Philips Healthcare, Aidoc, and Siemens Healthineers. One of the primary barriers is the disagreement in data protection and the lack of compatibility with ethical aspects.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content